Moxifloxacin
1 Inquiries
151096-09-2
2026-08-12
D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionKeywordsQuick DetailsProName:
Moxifloxacin
CasNo:151096-09-2
Molecular Formula:C21H24FN3O4
Appearance:Light yellow powder
Application:Biochemical research
DeliveryTime:prompt shipment
PackAge:25kg/drum
Port:Hangzhou,Shanghai,China
ProductionCapacity:/
Purity:98.0%~102.0%
Storage:cool and dry
Transportation:by sea ,air or express
LimitNum:1 Kilogram
Superiority
Characteristics： Light yellow or yellow powder or crystals Identification： Infrared absorption; The retention time of the major peak i…
Details
Characteristics： Light yellow or yellow powder or crystals
Identification： Infrared absorption;
The retention time of the major peak in the
chromatogram of the assay preparation
corresponds to that in the chromatogram of
the standard preparation,as obtained in the assay.
The filtrate meets the requirements of the tests
for chloride
Specific rotation ：-125°~ -138°
PH： 3.9~4.6
Water： ≤4.5%
Residue on ignition ：≤0.1%
Impurity A ≤0.1%
Impurity B ≤0.1%
Impurity C ≤0.1%
Impurity D ≤0.1%
Impurity E ≤0.1%
Individual impurity ：≤0.1%
Total impurities ：≤0.5%
Assay ：98.0%~102.0%
Basic Info-
Product Name:
Moxifloxacin
Other Name:3-Quinolinecarboxylic acid,1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-;3-Quinolinecarboxylic acid,1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-,(4aS-cis)-;6H-Pyrrolo[3,4-b]pyridine,3-quinolinecarboxylic acid deriv.;1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid;Moxifloxacin;Vigamox;Izilox;Moxifloxacine;Avolex;Moxeza;Rapiflox;Moxicip;195154-07-5
CAS No.:151096-09-2
Molecular Formula:C21H24FN3O4
InChIKeys:InChIKey=FABPRXSRWADJSP-MEDUHNTESA-N
Molecular Weight:401.43
Exact Mass:401.43
EC Number:1806241-263-5
UNII:U188XYD42P
DSSTox ID:DTXSID3048491
NCI Thesaurus Code:C62052
ATC Code:J01MA14|J - Antiinfectives for systemic use|S - Sensory organs
Categories:
Characteristics-
PSA:
82.1
XLogP3:2.9
Appearance:Solid
Density:1.408±0.06 g/cm3(Predicted)
Melting Point:240 °C
Boiling Point:636.4°C at 760 mmHg
Flash Point:338.7ºC
Refractive Index:1.633
Water Solubility:1.68e-01 g/L
Storage Conditions:Store in tight, light-resistant container as defined in the USP-NF. This material should be handled and stored per label instructions to ensure product integrity. /Moxifloxacin hydrochloride/
Vapor Pressure:7.26X10-15 mm Hg at 25 deg C (est)
Specific rotation:23D -193°
Henrys Law Constant:Henry's Law constant = 3.11X10-20 atm-cu m/mol at 25 °C (est)
Collision Cross Section:198.5 Ų [M+H]+ [CCS Type: TW, Method: calibrated with Waters Major Mix]|210.7 Ų [M+Na]+ [CCS Type: TW, Method: calibrated with Waters Major Mix]|202.63 Ų [M-H]-
Experimental Properties:Slightly yellow to yellow crystalline powder, mp 324-325 °C (decomposes), specific optical rotation: -256 °C at 25 °C/D (c = 0.5 in water) /Moxifloxacin hydrochloride/|Hydroxyl radical reaction rate constant = 1.28X10-10 cu cm/molec-sec at 25 °C (est)|Ozone radical reaction rate constant = 1.75X10-18 cu cm/molec-sec at 25 °C (est)
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Oral
Eye irritation, Category 2
Hazardous to the aquatic environment, long-term (Chronic) - Category Chronic 3
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Warning
Hazard statement(s) H302 Harmful if swallowed
H319 Causes serious eye irritation
H412 Harmful to aquatic life with long lasting effects
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P273 Avoid release to the environment.
Response P301+P317 IF SWALLOWED: Get medical help.
P330 Rinse mouth.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Storage none
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP
-
Location:
1613 Guangyin Building,No.42 E.Fengqi Road,Hangzhou,310012 China.
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
7
-
Total Annual Revenue:
$25 million-$50 million
-
Total Employees:
11-50
-
Year of Establishment:
2011
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted 
South Korea
Moxifloxacin
1 KG Jun 25, 2026 Post an enquiry for this product
